Richard Scheller - May 14, 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Stock symbol
ORIC
Transactions as of
May 14, 2021
Transactions value $
-$200,605
Form type
4
Date filed
5/18/2021, 08:20 PM
Previous filing
May 13, 2021
Next filing
May 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale -$117K -4.62K -9.42% $25.38 44.4K May 14, 2021 Direct F1, F2
transaction ORIC Common Stock Sale -$12.5K -500 -1.13% $25.06 43.9K May 17, 2021 Direct F1, F3
transaction ORIC Common Stock Sale -$71K -2.8K -6.38% $25.34 41.1K May 18, 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 4,615 shares sold in the price range of $25.00 to $25.84 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $25.00 to $25.12 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average share price of an aggregate total of 2,800 shares sold in the price range of $25.00 to $25.68 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

Exhibit 24 - Power of Attorney